Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

被引：11

作者：

Gardini, A. C. ^{[1
]}

Foschi, F. G. ^{[2
]}

Conti, F. ^{[3
]}

Petracci, E. ^{[4
]}

Marisi, G. ^{[5
]}

Buonfiglioli, F. ^{[3
]}

Ravaioli, M. ^{[3
]}

Mazzella, G. ^{[6
]}

Muratori, P. ^{[7
,8
]}

Lenzi, M. ^{[7
,8
]}

Crespi, C. ^{[9
]}

Bolondi, L. ^{[6
]}

Badia, L. ^{[10
]}

Verucchi, G. ^{[3
]}

Vitale, G. ^{[3
]}

Vukotic, R. ^{[3
]}

Brillanti, S. ^{[3
]}

Andreone, P. ^{[3
]}

机构：

[1] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy

[2] AUSL Romagna, DPT Internal Med, Faenza Hosp, Forli, Italy

[3] Univ Bologna, Res Ctr Study Hepatitis, Dept Med & Surg Sci DIMEC, Bologna, Italy

[4] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Unit Biostat & Clin Trials, Meldola, Italy

[5] IRST IRCCS, Biosci Lab, Meldola, Italy

[6] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy

[7] Policlin St Orsola, Ctr Study & Treatment Autoimmune Dis Liver & Bili, Bologna, Italy

[8] Univ Bologna, Dept Med & Surg Sci DIMEC, Alma Mater Studiorum, Bologna, Italy

[9] St Orsola Marcello Malpighi Hosp, Dept Digest Dis, Bologna, Italy

[10] Univ Bologna, Infect Dis Unit, Dept Med & Surg Sci, Hosp S Orsola Malpighi, Bologna, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2018年 / 50卷 / 01期

关键词：

D O I：

10.1016/j.dld.2018.01.055

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

F-17

引用

页码：50 / 51

页数：2

共 50 条

[1] Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Conti, Fabio
Buonfiglioli, Federica
Scuteri, Alessandra
Crespi, Cristina
Bolondi, Luigi
Caraceni, Paolo
Foschi, Francesco Giuseppe
Lenzi, Marco
Mazzella, Giuseppe
Verucchi, Gabriella
Andreone, Pietro
Brillanti, Stefano
JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 727 - 733
[2] Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals
Gardini, Andrea Casadei
Foschi, Francesco Giuseppe
Conti, Fabio
Petracci, Elisabetta
Vukotic, Ranka
Marisi, Giorgia
Buonfiglioli, Federica
Vitale, Giovanni
Ravaioli, Federico
Gitto, Stefano
Verucchi, Gabriella
Lenzi, Marco
Bolondi, Luigi
Mazzella, Giuseppe
Brillanti, Stefano
Andreone, Pietro
Scuteri, Alessandra
Cursaro, Carmela
DIGESTIVE AND LIVER DISEASE, 2019, 51 (05) : 681 - 688
[3] Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)
Calvaruso, V.
Cabibbo, G.
Cacciola, I.
Petta, S.
Madonia, S.
Bellia, A.
Tine, F.
Distefano, M.
Giannitrapani, L.
Prestileo, T.
Mazzola, G.
Davi, A.
Larocca, L.
Ardiri, A.
Digiacomo, A.
Gussio, M.
Guarneri, L.
Magro, A.
Averna, A.
Iacobello, C.
Scalisi, I.
Cartabellotta, F.
Savalli, F.
Russello, M.
Scifo, G.
Squadrito, G.
Camma, C.
Raimondo, G.
Craxi, A.
Di Marco, V.
DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E60 - E60
[4] RISK OF HEPATOCELLULAR CARCINOMA IN HCV-RELATED CIRRHOSIS TREATED WITH DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
Kilany, Shimaa
Gomaa, Asmaa Ibrahim
Sabry, Alyaa
Moaz, Inas
Ezzat, Sameera
Badra, Gamal Ahmed
Waked, Imam
HEPATOLOGY, 2019, 70 : 321A - 322A
[5] Pro: Direct-acting antivirals are associated with occurrence and recurrence of hepatocellular carcinoma
Trotter, James F.
LIVER TRANSPLANTATION, 2017, 23 (12) : 1593 - 1595
[6] Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma
Marrero, Jorge A.
Singal, Amit G.
LIVER TRANSPLANTATION, 2017, 23 (09) : 1099 - 1100
[7] Pretransplantation Direct-acting Antivirals Provides a Safe and Effective without Increase Recurrence of Hepatocellular Carcinoma in HCV-related HCC Patients
Yin, S. M.
Chen, C. L.
Lin, C. C.
Wang, C. C.
Wang, S. H.
Liu, Y. W.
Yong, C. C.
Lin, T. L.
Li, W. F.
Lin, Y. H.
Chan, Y-C
Yeh, C-S
TRANSPLANTATION, 2017, 101 (05) : 42 - 43
[8] Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals
Russo, Francesco Paolo
Zanetto, Alberto
Campello, Elena
Bulato, Cristiana
Shalaby, Sarah
Spiezia, Luca
Gavasso, Sabrina
Franceschet, Enrica
Radu, Claudia
Senzolo, Marco
Burra, Patrizia
Lisman, Ton
Simioni, Paolo
LIVER INTERNATIONAL, 2018, 38 (12) : 2210 - 2218
[9] Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals
Hasson, Hamid
Merli, Marco
Messina, Emanuela
Bhoori, Sherrie
Salpietro, Stefania
Morsica, Giulia
Regalia, Enrico
Bagaglio, Sabrina
Lazzarin, Adriano
Uberti-Foppa, Caterina
Mazzaferro, Vincenzo
JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 415 - 417
[10] Improved recurrence-free survival rates in patients with HCV-related hepatocellular carcinoma and sustained virological response to direct-acting antivirals
Muzica, Cristina-Maria
Trifan, Anca
Huiban, Laura
Stoica, Oana
Girleanu, Irina
Chiriac, Stefan
Singeap, Ana-Maria
Cojocariu, Camelia
Cuciureanu, Tudor
Zenovia, Sebastian
Nastasa, Robert
Stanciu, Carol
JOURNAL OF HEPATOLOGY, 2022, 77 : S573 - S574

← 1 2 3 4 5 →